Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01144520 · ClinicalTrials.gov registry record
Leukocyte Dysfunction in Diabetic Patients.
A clinical trial, sponsored by Sashwati Roy.
- Terminated
- Registry status
- 42
- Enrollment target
NCT01144520: Clinical Trial study, sponsored by Sashwati Roy.
NCT01144520 is a clinical trial that was terminated before completion, run by Sashwati Roy. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01144520 was terminated before completion, sponsored by Sashwati Roy.
- TERMINATED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to study impairment of white blood cell function in patients with type II diabetes.
Primary Outcome
After blood draw monocytes are separated from whole blood and production of oxidants by these cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-03 |
| Est. Completion | 2018-12 |
Why NCT01144520 stopped before completion
NCT01144520 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01144520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01144520 about?
NCT01144520 is a clinical study titled "Leukocyte Dysfunction in Diabetic Patients.". The purpose of this study is to study impairment of white blood cell function in patients with type II diabetes.
What is the current status of trial NCT01144520?
This trial is currently terminated. The enrollment target is 42 participants. The study started on 2010-03. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01144520?
This trial is sponsored by Sashwati Roy, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia